To include your compound in the COVID-19 Resource Center, submit it here.

Cancer aggregator

How MPM formed Cullinan to amass the best of its single asset cancer deal flow

MPM Capital launched Cullinan Oncology LLC to aggregate cancer assets that on their own would be too risky to build a company around. The firm believes by amassing up to 10 projects at any given time, the company can diversify its

Read the full 414 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers